Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Weintraub

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Vaccine|May 21, 2011
Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenzaNatalie L McCarthy, Julianne Gee, Eric Weintraub, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
The Journal of Infectious Diseases|November 2, 2020
Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 SeasonSilvia Perez-Vilar, Mao Hu, Eric Weintraub, et al.
American Journal of Otolaryngology|August 3, 2024
Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalinkW Katherine Yih, Jonathan Duffy, John R Su, et al.
Pharmacoepidemiology and Drug Safety|November 18, 2017
The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink studyMatthew F Daley, Christina L Clarke, Jason M Glanz, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
American Journal of Preventive Medicine|June 25, 2013
Mortality rates and cause-of-death patterns in a vaccinated populationNatalie L McCarthy, Eric Weintraub, Claudia Vellozzi, et al.
Open Forum Infectious Diseases|July 7, 2018
Pneumococcal Conjugate Vaccine Safety in Elderly AdultsHung Fu Tseng, Lina S Sy, Lei Qian, et al.
American Journal of Preventive Medicine|January 21, 2014
Vaccinations given during pregnancy, 2002-2009: a descriptive studyAllison L Naleway, Samantha Kurosky, Michelle L Henninger, et al.
JAMA Network Open|April 12, 2023
Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical TrialAnnabelle M Belcher, Thomas O Cole, Ebonie Massey, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Vaccine|May 21, 2011
Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenzaNatalie L McCarthy, Julianne Gee, Eric Weintraub, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
The Journal of Infectious Diseases|November 2, 2020
Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 SeasonSilvia Perez-Vilar, Mao Hu, Eric Weintraub, et al.
American Journal of Otolaryngology|August 3, 2024
Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalinkW Katherine Yih, Jonathan Duffy, John R Su, et al.
Pharmacoepidemiology and Drug Safety|November 18, 2017
The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink studyMatthew F Daley, Christina L Clarke, Jason M Glanz, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
American Journal of Preventive Medicine|June 25, 2013
Mortality rates and cause-of-death patterns in a vaccinated populationNatalie L McCarthy, Eric Weintraub, Claudia Vellozzi, et al.
Open Forum Infectious Diseases|July 7, 2018
Pneumococcal Conjugate Vaccine Safety in Elderly AdultsHung Fu Tseng, Lina S Sy, Lei Qian, et al.
American Journal of Preventive Medicine|January 21, 2014
Vaccinations given during pregnancy, 2002-2009: a descriptive studyAllison L Naleway, Samantha Kurosky, Michelle L Henninger, et al.
JAMA Network Open|April 12, 2023
Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical TrialAnnabelle M Belcher, Thomas O Cole, Ebonie Massey, et al.
Pageof 12